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Abstract 
 
 
PO2 DEPENDENCE OF OXYGEN CONSUMPTION IN 
SKELETAL MUSCLE OF DIABETIC AND NON-DIABETIC 
RATS 
 
By: Alexander C. Liles 
 
A thesis submitted in partial fulfillment of the requirements for the degree of Master of 
Science at the Medical College of Virginia Campus, Virginia Commonwealth University 
 
Virginia Commonwealth University, 2017 
 
Advisor: Roland N. Pittman, Ph.D. 
  Department of Physiology and Biophysics 
 
 Type 2 diabetes mellitus (T2DM) is a major medical problem around the world, 
affecting nearly 6% of the world’s population. This study was an attempt to better 
understand physiological changes the disease may cause to the microcirculation and 
more specifically, to assess the PO2 dependence of oxygen consumption in skeletal 
muscle of a diabetic animal model. The spinotrapezius muscles of Goto-Kakizaki (G-K) 
and Wistar control rats were used to measure interstitial PO2 using phosphorescence 
quenching microscopy. The G-K rats spontaneously develop T2DM and serve as an 
appropriate model for the disease in humans. By rapidly arresting blood flow in the 
tissue and observing the resulting PO2 changes, an oxygen disappearance curve (ODC) 
was created. The ODC was used to calculate oxygen consumption rate (VO2) over the 
physiological range of PO2 values. The resulting VO2 vs PO2 curves were analyzed 
using Hill’s equation to fit the data and obtain values of several key parameters to 
   8 
quantitatively describe the PO2 dependence of oxygen consumption. When compared 
to healthy control rats, the G-K rats exhibited a significantly higher Vmax, or maximum 
rate of oxygen consumption, compared to the Wistar rats. The two rat sub-strains had 
similar values for P50, which indicates the PO2 at half maximal consumption. The 
overall higher maximal rate of consumption by the diseased animals could be 
explained by some disconnect in the consumption of oxygen by the mitochondria and 
the normal corresponding production of ATP. In conclusion, it was demonstrated that 
in situ muscle tissue from both diabetic and non-diabetic rats had a PO2 dependence 
of oxygen consumption over a wide range of PO2 values and the muscles of diabetic 
animals consumed oxygen at a higher maximal rate. 
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Introduction 
 
Cellular Need for Energy 
 
 The vast array of functions that are carried out by the cell in an organism 
require a constant input of energy in the form of adenosine triphosphate (ATP). In the 
presence of oxygen, oxidative phosphorylation within the mitochondria is the most 
efficient mechanism for production of this high-energy molecule. Since oxygen is 
required for this process to take place, the delivery of O2 from the atmosphere to the 
cell is critical for maintenance of normal cellular function. 
 
The Blood and Circulation 
 
 The requirement for a continuous and adequate supply of oxygen to the cell for 
energy production by the mitochondria is accomplished through an orchestrated 
effort between the cardiovascular and respiratory systems. Blood is oxygenated in the 
pulmonary capillaries of the lungs by the diffusion of oxygen from the nearby alveoli; 
the oxygenated blood is pumped by the heart through the circulation (Costanzo, 
1998). Almost all of the oxygen in the blood is carried by the protein hemoglobin, 
contained within the red blood cells (RBCs), which has four binding sites for oxygen. 
When the oxygen bound to hemoglobin is delivered to tissue through the capillaries, 
the oxygen is released from the hemoglobin and can diffuse through the RBC 
cytoplasm, across the RBC membrane, through the plasma and across the capillary 
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wall into the interstitial fluid. Here the oxygen can move into cells and be used to 
generate ATP (Pishchany G, 2012). 
 
The relationship between oxygen bound to hemoglobin (oxygen saturation, 
SO2) and the partial pressure of oxygen (PO2) can be described by the oxygen 
saturation (or dissociation) curve. The curve is sigmoidal in shape and illustrates the 
binding properties of hemoglobin. As PO2 increases, the oxygen saturation also 
increases. In oxygen-rich arteriolar blood, on the one hand, hemoglobin is highly 
saturated with oxygen. On the other hand, oxygen is unloaded from the RBCs in areas 
with lower PO2, such as capillary beds of skeletal muscle (Pittman, 2011). When 
certain physiological changes take place in the body (e.g., altered temperature, pH, 
PCO2), the dissociation curve will shift to adjust the availability of oxygen to tissues. 
For example, an increase in temperature due to exercise shifts the curve to the right 
and therefore decreases the affinity of hemoglobin for oxygen. This allows oxygen to 
be released more easily from hemoglobin and increases its availability to muscle cells. 
 
After oxygen is delivered to the microcirculation by oxygenated RBCs, it must 
make its way into the parenchymal cells by diffusion. The diffusion is driven by partial 
pressure gradients in oxygen that drive oxygen out of the capillaries, into the 
interstitial fluid, and eventually into the cell, as needed. As the mitochondria within 
the cell consume oxygen to make ATP, the PO2 within the cell decreases and draws 
more O2 into the cell from the interstitial fluid (Costanzo, 1998). 
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Glucose 
 
 Energy is required for normal functioning of body tissues, and glucose is the 
main substrate used by the body. Glucose is transported throughout the body in the 
blood and can be measured as “blood sugar.” Serum glucose levels are normally 
tightly regulated through uptake and release mechanisms. Glucose can be stored in 
the liver as glycogen and then mobilized back to glucose as needed by the body. The β-
cells of the pancreas release insulin when high blood sugar is detected in order to 
stimulate the uptake of glucose from the bloodstream. It has been shown that chronic 
exposure to high blood glucose can reduce the response of the β-cells, leading to 
complications like diabetes. Additionally, repeated stimulation by insulin and 
prolonged high levels of insulin can lead to insulin resistance, which is a major 
characteristic of Type 2 diabetes (White M.F., 1998). 
 
As carbohydrates are consumed, they are broken down by the body and used 
to create energy. During glucose metabolism, glucose is oxidized to yield carbon 
dioxide and water while simultaneously producing energy in the form of ATP. The 
first step in the breakdown of glucose is glycolysis. As a result of glycolysis, pyruvate 
is produced. Under aerobic conditions, most pyruvate is oxidized and enters the Tri-
carbolic acid (TCA) cycle, which has a high yield of ATP. For cellular respiration to be 
completed, NADH and FADH2 produced during the earlier stages serve as electron 
donors in the electron transport chain (ETC). The ETC is an ordered series of proteins 
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embedded in the inner membrane of the mitochondria. Electrons are passed from one 
protein to the next in redox reactions that create a proton gradient across the 
membrane. This gradient is used to subsequently produce ATP. The ETC, along with 
this production of ATP via proton gradients, is known as oxidative phosphorylation. 
Oxygen is the terminal electron acceptor in the ETC and is therefore required for 
oxidative phosphorylation to occur. In anaerobic conditions, fermentation occurs, 
resulting in the production of lactate and a significantly lower ATP yield. 
 
PO2 Dependence of Oxygen Consumption 
 
The mitochondria consume the vast majority (>95%) of oxygen that enters the 
cell for normal cellular respiration. The classic view of mitochondrial respiration is 
that consumption occurs at a constant rate regardless of shifts in the amount of 
oxygen in the area, unless the PO2 falls below approximately 1 mmHg (Wilson, 1985). 
This view suggests that oxygen consumption is essentially independent of PO2 under 
typical physiological conditions. Normal cellular respiration would be maintained 
even at relatively low or relatively high concentrations of oxygen as long as the PO2 
was above that critical level. This idea is supported by numerous in vitro studies that 
measured oxygen consumption rates in mitochondrial suspensions (Wilson, 1988). 
The oxygen dependence of respiration was later addressed using in vivo methods, 
which demonstrated that the mitochondria do not function in such an all-or-nothing 
or on/off manner (Golub, 2012). Based on these experiments, the rate of oxygen 
consumption appears to vary over a wide range of physiological PO2 levels. 
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The PO2 dependence of oxygen consumption can be illustrated by plotting 
oxygen consumption rate (VO2) versus corresponding PO2 values. In the context of 
using Michaelis-Menten kinetics to this PO2 dependence, this allows the maximal rate 
of consumption (Vmax) and also the half-maximal rate (at PO2 = Km) to be calculated. 
The classic view of PO2 dependence suggests a Km for oxygen consumption that is well 
below 1 mmHg (Wilson, 1988). However, recent in vivo studies concluded that the Km 
in rat spinotrapezius muscle was approximately 10 mmHg (Golub & Pittman, 2012). 
This is a staggering difference that demonstrates oxygen consumption depends much 
more on varying PO2 levels than previously thought. 
 
Phosphorescence Quenching Microscopy 
 
The in vivo studies described above involve measuring PO2 of the interstitial 
fluid of skeletal muscle in rats using phosphorescence quenching microscopy (PQM) 
(Pittman R.N., 2012). PQM is an innovative approach to measuring oxygen tension 
that involves exciting a phosphor probe molecule from the ground state to an excited 
state using a brief flash from a light source, such as a laser. The excited phosphor 
molecule can return to the ground state by either emitting a photon 
(phosphorescence), or being quenched by oxygen (collisional quenching). The PO2 can 
be calculated based on this relationship using the Stern-Volmer equation. The 
intensity of the phosphorescent light emission can be described by the following: 
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(1)    𝐼𝑝ℎ𝑜𝑠(𝑡) =  𝐼𝑝ℎ𝑜𝑠(0) 𝑒
−𝑘𝑡 
 
 
In this equation, 𝐼𝑝ℎ𝑜𝑠(𝑡) is the intensity of the phosphorescent light emission, 𝐼𝑝ℎ𝑜𝑠(0) 
is the phosphorescence intensity at t = 0, and k is the phosphorescence (exponential) 
decay rate. Once the decay rate (k) is obtained, the PO2 can be related to it with this 
formula: 
 
(2)    𝑘 =  𝑘0 +  𝑘𝑞𝑃𝑂2 
 
 
The quenching coefficient (kq) and the decay rate at zero PO2 (k0) are constants 
determined in separate calibration experiments (Golub, 2010). 
 
 When measuring the PO2 of the interstitial space, the phosphorescent oxygen 
probe can be bound to albumin to prevent it from penetrating the cell and 
vasculature. When using a thin skeletal muscle, the dissolved probe can be loaded into 
the interstitium by simple topical application. After sufficient time has passed to allow 
for diffusion of the probe into the interstitial space (30-60 min), the tissue will be 
ready for determination of PO2 by PQM (Nugent et al, 2015). Once PO2 readings can be 
taken from the muscle, a “stop-flow” approach can be used to find the rate of oxygen 
consumption based on the subsequent decrease in oxygen tension over time. When 
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blood flow is halted, the tissue will continue to consume the available dissolved 
oxygen and the PO2 will fall until it reaches approximately 0 mmHg. 
 
Type 2 Diabetes Mellitus 
 
 Type 2 diabetes mellitus (T2DM) is characterized by a variety of dysfunctions 
that are caused by insulin resistance and inadequate insulin secretion. This results in 
chronic hyperglycemia and an assortment of related issues. It is a major disease that 
affects approximately 9.3% of the U.S. population and is increasing in prevalence 
worldwide (CDC). The major risk factors for T2DM include physical inactivity, poor 
diet, obesity, and increasing age. β-cells of pancreatic islets are involved in the 
secretion of insulin, which promotes the absorption of glucose from the bloodstream 
into the liver, fat, and skeletal muscle cells (Akash, 2013). The disease is known to 
occur as a consequence of β-cell dysfunction and reduction in β-cell size, which affects 
the secretion of insulin. 
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Goto-Kakizaki Rats: T2DM Animal Model 
 
 In order to study the effect of T2DM on the PO2 dependence of oxygen 
consumption, a suitable animal model for the disease is required. Goto-Kakizaki (GK) 
rats are considered to be one of the best subspecies developed for the study of 
spontaneous T2DM (Akash, 2013). They were developed from selective inbreeding of 
Wistar rats, which serve as the best control group when research is being performed 
with these G-K rats. 
 
 GK rats share many significant characteristics with human diabetic patients 
including hyperglycemia, reduced β-cell mass, insulin resistance, and impaired 
glucose-induced insulin secretion (Akash, M, 2013). In order to help differentiate the 
impact of obesity and T2DM on hyperglycemia, they were developed as a non-obese 
model. G-K rat body weight is typically 10-30% lower than their age-matched Wistar 
control (Akash, M, 2013). Approximately 3 weeks after birth, these rats suddenly 
develop the characteristics mentioned above that accurately model T2DM. Similar to 
humans, the disease symptoms progress as they age. In adulthood, the rats often 
exhibit renal damage and proteinuria, which can be compared to diabetic 
nephropathy in humans. Overall, Goto-Kakizaki rats are a suitable non-obese animal 
model to investigate type 2 diabetes mellitus. 
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Purpose of Study 
 
 This project was initiated in order to study the PO2 dependence of oxygen 
consumption in healthy and diabetic rats. It has been previously demonstrated in 
related in vivo studies that the oxygen consumption rate by the mitochondria of 
skeletal muscle cells is dependent on variations in PO2 over a much wider 
physiological range than previously proposed (Golub AS, Pittman RN, 2012). To 
further investigate this concept, we decided to see if this dependence would change in 
a diseased animal model. Type 2 diabetes mellitus has broad metabolic effects 
primarily characterized by hyperglycemia and can be modeled well with Goto-
Kakizaki rats. We sought to determine whether there was a difference in the oxygen 
dependence of respiration in the spinotrapezius muscles of healthy and diabetic rats 
by analyzing the disappearance rate of oxygen, following flow arrest, using 
phosphorescence quenching microscopy. 
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Materials and Methods 
 
 
Animals and Surgical Preparations 
 
Male Wistar rats (ENVIGO, Madison, WI, weight = 295.4 ± 23.2 g, N=5) served 
as the control group and male Goto-Kakizaki rats (Taconic Farms, Derwood, MD, 
weight = 249.8 ± 15.0 g, N=5) were used to characterize the PO2 dependence of 
oxygen consumption in diabetic animals. Animals were housed in plastic cages with 2 
rats per cage under a 12-hour/12-hour light/dark cycle. All animals received equal 
quantities of rat chow and water, which was provided by the Division of Animal 
Resources. There was continuous ventilation in a climate-controlled vivarium 
maintained at 20-23 degrees Celsius. 
To perform the intravital microscopic studies, rats first underwent a surgical 
procedure to exteriorize the spinotrapezius muscle. Each rat was initially 
anesthetized with a Ketamine/Acepromazine (72/3 mg/kg) solution by 
intraperitoneal injection. After the rat was sufficiently anesthetized (about 10 minutes 
post-injection established by toe pinch), it was shaved in the bilateral inguinal 
creases, ventral neck region, and an area from the shoulder blades extending along 
the spine covering the spinotrapezius muscle using clippers. A depilatory cream (Nair, 
Church and Dwight Co., Inc., Ewing, NJ) was applied to remove any remaining hair. 
The animal was then placed under a stereomicroscope on a heating pad, to maintain 
core body temperature at 37 °C, in preparation for surgery. Blood glucose readings 
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were taken from the paw of the back left foot before and after each experiment using 
an AlphaTrak Blood Glucose Monitoring System (Zoetis Inc., Kalamazoo, MI). At the 
conclusion of the experiment, the rat was euthanized with Euthasol (150 mg/kg). 
 
Femoral Vein Cannulation 
 
Initially, an incision was made along the right inguinal crease and the right 
femoral vein was isolated. An incision was made perpendicular to the vein about half 
the diameter of the vessel. Before this incision was made, a knot was secured just 
distally to arrest blood flow through the vein. A cannula consisted of 26 cm of 
polyethylene tubing (PE 90) connected to a 6 ml syringe containing Alfaxan (Jurox 
Inc., Kansas City, MO, alfaxalone 10 mg/mL) and a 10 ml syringe containing 
heparinized phosphate-buffered saline (PBS). The Alfaxan was continually infused at 
0.1 mg/kg/min for the duration of the experiment. This infusion rate was adjusted as 
necessary to maintain appropriate surgical depth of anesthesia based on toe pinch 
reflex and heart rate. The cannula was secured to the animal’s leg using Transpore 
tape; and a cotton ball was taped over the incision to prevent drainage of any fluids. 
This cannula was also used to infuse Euthasol at the conclusion of the experiment to 
euthanize the animal. 
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Tracheostomy 
 
Immediately following the femoral vein cannulation, the trachea was 
cannulated with polyethylene tubing (PE 240) to ensure a patent airway for the 
duration of the experiment. This incision was taped down and secured with a cotton 
ball. The animal breathed room air spontaneously. 
 
Spinotrapezius Muscle Preparation 
 
The spinotrapezius muscle was exteriorized following the procedures 
described by (Gray, 1973) and placed on a thermo-stabilized platform for intravital 
microscopy (Golub and Pittman, 2003). Initially, an incision was made longitudinally 
along the dorsal midline of the rat between the shoulder blades and extending down 
the spine to expose the underlying fascia. The fascia was removed carefully and a 
cauterizing pen was used to minimize bleeding. After the muscle was exposed, tissue 
hydration was maintained by topical application of PBS as needed. At this point, the 
muscle was carefully separated from the underlying fascia using curved scissors and 
placed on the platform. Surgical silk (size = 6-0) was sutured every 2 cm around the 
border of the muscle to aid with securing the muscle to the platform. Excessive 
stretching or manipulation of the muscle was avoided to prevent damage to any 
vessels. 
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Figure 1. Photograph of a spinotrapezius muscle prepared for intravital microscopy 
and PQM. 
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Phosphorescent Probe Application 
 
Prior to mounting the heated animal platform to the microscope, 2 ml of the 
phosphorescent oxygen probe (Pd-meso-tetra-(4-carboxyphenyl)porphyrin (Oxygen 
Enterprises, Philadelphia, PA) conjugated to human serum albumin in PBS) was 
topically applied to the spinotrapezius muscle at a concentration of 10 mg/ml and 
allowed to diffuse into the muscle for 60 minutes. It can be assumed that the probe 
does not enter the muscle fibers because it was bound to albumin, which is too large 
to pass through the cell membrane. Any residual probe that entered the 
microvasculature would be immediately “washed out” by blood flow. Therefore, it 
was determined that measurements taken from exciting the probe that diffused into 
the tissue in this manner would be confined to the interstitial fluid space. After the 
probe was applied, the muscle was covered with a gas-impermeable film (Krehalon, 
CB-100; Krehalon Limited, Japan) to isolate it from the room air. 
 
Phosphorescence Quenching Microscopy 
 
After the probe was distributed within the interstitial space, the animal 
platform was mounted on an Axioplan-2 microscope (Zeiss, Germany) in preparation 
for phosphorescence quenching microscopy studies. To excite the probe, pulses from 
a laser were produced at a rate of 1 Hz. A photomultiplier tube collected the 
phosphorescence emitted from the excited probe and a colored-glass long-pass filter 
(OG 550, Edmund Optics) was in place to avoid extraneous excitation. A video camera 
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was also used to aid in visually selecting well-perfused sites in the muscle and ensure 
that the pneumatic tissue compression fully evacuated the RBC’s from the site. The 
phosphorescence signal collected by the PMT was transmitted through an amplifier to 
an analog-to-digital converter. This allowed the phosphorescence decay curves to be 
analyzed by custom data processing software using the National Instruments 
platform. A 𝑃𝑂2 value was produced for each phosphorescence decay curve using the 
analysis software. 
 An additional consideration when measuring PO2 using this technique is the 
photoconsumption of oxygen. As described in the introduction, singlet oxygen is 
produced by the interaction of the probe and O2. The singlet oxygen can react with 
organic molecules and is therefore “consumed” by the method. This proportional 
reduction in PO2 needs to be accounted for by calculating a coefficient (K) that is 
related to photoconsumption. This is accomplished by measuring PO2 at two different 
excitation frequencies using a 5 s x 15 s high/low pressure cycling method (Nugent et 
al, 2015). For a total of 100 seconds, a series of 5 second compressions each followed 
by 15 seconds with no compression, alternating between the high and low 
frequencies were measured. The PO2 changes were then compared to calculate the 
photoconsumption coefficient using the following formula: 
 
(3)   K = [(dPn/dn)1 – (dPn/dn)2]/[(FP0)2 – (FP0)1] 
 
   24 
In Equation 3: F is the flash rate for each measurement, dPn/dn is the rate of oxygen 
disappearance per flash at the given high or low frequency, P0 is the steady state PO2 
at the given flash rate prior to pneumatic compression.  
 
  
Phosphorescence Decay Curve Analysis 
 
A non-linear fitting program was used for each phosphorescence decay curve 
that was based on the rectangular 𝑃𝐼𝑆𝐹𝑂2 distribution model (Golub et al., 1997). The 
fitting program was used to obtain a continuous line fit for each decay curve calculate 
the phosphorescence decay rate. The fitting equation used was as follows: 
 
(4)  𝐼(𝑡) = 𝐼0 exp[−(𝐾0 + 𝐾𝑞𝑀)𝑡] sinh(𝐾𝑞𝛿𝑡)/𝐾𝑞𝛿𝑡 + 𝐵 
 
in which t is time in μs from the beginning of the decay, I(t) is the phosphorescence 
decay curve in volts, 𝐼0 is the magnitude of the phosphorescence signal at t = 0, M is 
the average 𝑃𝑂2 (mmHg) in the region being measured, δ (mmHg) is the half-width of 
the uniform 𝑃𝑂2 distribution, and B (volts), is the baseline offset of the amplifier. 𝐾0 
and 𝐾𝑞 serve as constants and have been determined from calibration experiments 
(Golub and Pittman, 2016) to be 𝐾0 = 1.53 x 10
−4 μs−1 and 𝐾𝑞 = 4.3 x 10
−4 μs−1 
𝑚𝑚𝐻𝑔−1. 
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Tissue Compression 
 
An airbag mounted on the objective lens of the microscope was used to arrest blood 
flow in the spinotrapezius muscle. The airbag was rapidly inflated (<1s) to 
approximately 150 mmHg, which is higher than systolic pressure, causing blood flow 
to cease and extrude most of the red blood cells from that region. This was confirmed 
by visually inspecting the site using the video camera. After the tissue was 
compressed, a fall in 𝑃𝑂2 was observed as the tissue consumed the remaining 
dissolved oxygen. For each animal, five well-perfused sites were chosen to measure 
𝑃𝑂2 during the compression cycle. Measurement sites were chosen based on specific 
criteria: it was required that the site was well perfused with continuous RBC flow and 
was not close to any large vessels. 
To obtain a baseline 𝑃𝑂2 for each site, the 𝑃𝑂2 was measured for 10 seconds 
prior to compression. After the airbag was inflated, 𝑃𝑂2 continued to be measured for 
an additional 60 seconds in order to observe the complete disappearance of oxygen. 
The tissue was allowed to rest with no compression or excitation for 5 minutes 
between measurements at each site. 
 
 
Analysis of Oxygen Consumption 
 
For each site, an oxygen disappearance curve (ODC) was observed as the 𝑃𝑂2 
decreased during compression. The rate of 𝑃𝑂2 change after the blood flow had been 
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arrested with the airbag was related to several factors. First, the tissue consumed 𝑂2 
as a part of normal respiration. Additionally, consumption by the method itself 
(photoconsumption) and 𝑂2 diffusion into the excitation region had to be accounted 
for. It was important to account for these factors in order to accurately calculate the 
𝑂2 consumed specifically by tissue respiration. 
The ODC was used to calculate the oxygen consumption rate (𝑉𝑛) at a given 
𝑃𝑂2, which is necessary to determine the 𝑃𝑂2 dependence of oxygen consumption. 
The relationship between 𝑉𝑛 and 𝑃𝑂2 is described by the following formula: 
 
 (5)   
𝑑𝑃𝑛
𝑑𝑛
=  −𝑉𝑛 − 𝐾𝑃𝑛 + 𝑍(𝑃𝑛 − 𝑃𝑛) 
 
in which 
𝑑𝑃𝑛
𝑑𝑛
  is the rate of 𝑂2  disappearance per flash, K is the coefficient related to 
consumption by the PQM method, and Z is the coefficient related to inward diffusion 
of 𝑂2 into the excitation region. The area being compressed is large enough so that the 
passive inward diffusion of 𝑂2 can be neglected. 
 
Statistics 
 
The values expressed in tables and the text are mean ± SE (N).  A t-test was 
conducted in comparisons between G-K and Wistar results to test for 
significance.  Statistical significance was assigned for p<0.05. 
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Results 
 
 
 
The goal of this study was to determine whether there was any difference in 
the oxygen dependence of oxygen consumption between diabetic and non-diabetic 
animals. These data were collected using the “flow arrest” approach described in the 
preceding Materials and Methods section.  
 
 
Oxygen Disappearance Curves 
 
 
Following each spinotrapezius muscle compression, an oxygen disappearance 
curve (ODC) was produced using the collected PO2 data and flash number 
(proportional to time). These ODC’s were corrected for consumption by the PQM 
method using Equation 3. During the first 10 seconds of collection, the muscle was not 
compressed and the baseline PO2 was established. After 10 seconds, the airbag was 
inflated and the disappearance curve was created based on the decrease in PO2.  
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Oxygen Disappearance Curve – Wistar Rat 
 
 
 
 
 
 
 
 
 
 
Figure 2. This is an example of a typical oxygen disappearance curve collected from a 
Wistar rat using the PQM method. The laser was flashed at 1 Hz, so a new PO2 value 
was measured every second. 
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Oxygen Disappearance Curve - Goto-Kakizaki Rat 
 
 
 
 
 
 
 
 
 
Figure 3: The oxygen disappearance curve above is a representative curve from a 
single site on the spinotrapezius muscle of a Goto-Kakizaki rat. 
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PO2 Dependence of VO2 
 
 
The oxygen disappearance curves were used to calculate VO2 for each PO2 
value. Plots of VO2 vs. PO2 were created and these plots were then fit with Hill’s 
equation (Equation 6). 
 
 
(6)                                                     𝑽𝑶𝟐 =
𝑽𝒎𝒂𝒙 × 𝑷𝒏
𝒂
𝑷𝟓𝟎
𝒂 + 𝑷𝒏
𝒂   
 
 
In Hill’s equation, Pn represents the PO2 at a given flash number in the ODC and VO2, 
Vmax is the maximal rate of respiration, P50 is the PO2 at half-maximal respiration, and 
a is the Hill coefficient. 
 
After fitting the data for the VO2 vs. PO2 plots with Hill’s equation, the best-fit 
parameters, Vmax, P50 and a, were obtained. The mean Vmax for the Wistar control rats 
was 131.9 ± 8.7 (SE) nl 𝑂2/(𝑐𝑚
3*s). The mean P50 in the control group was 8.0 ± 0.6 
(SE) mmHg. The spontaneously diabetic Goto-Kakizaki rats had an average Vmax of 
215.9 nl 𝑂2/(𝑐𝑚
3*s) with a standard error of 23.0 and the mean P50 was 8.5 mmHg 
with a standard error of 0.5.  
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VO2 vs. PO2 Plot – Wistar Rat 
 
 
 
 
 
 
 
Figure 4. This is a typical plot of VO2 vs. PO2 that is used to assess the oxygen 
dependence of respiration in rat spinotrapezius muscle. The above example is taken 
from a single site on the spinotrapezius muscle of a Wistar rat. The Hill parameters 
calculated by fitting these data were as follows: Vmax = 181.4 nl O2/(cm3s), P50 = 6.5 
mmHg, a = 2.3, r2 = 0.99. 
 
See Appendix for full collection of VO2 vs. PO2 plots from Wistar rats. 
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VO2 vs. PO2 Plot – Goto-Kakizaki Rat 
 
 
 
 
 
 
 
 
 
 
Figure 5. The above plot was derived from analyzing an oxygen disappearance curve 
measured from a Goto-Kakizaki rat. The Hill parameters calculated by fitting these 
data were as follows: Vmax = 243.5 nl O2/(cm3s), P50 = 7.6 mmHg, a = 1.9, r2 = 0.99. 
 
See Appendix for a full collection of VO2 vs. PO2 plots from Goto-Kakizaki rats. 
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Table 1: The table above shows the best-fit values for Vmax, P50, and a (mean ± SE) for 
Wistar and Goto-Kakizaki rats. The maximal rate of oxygen consumption in the G-K 
rats was significantly higher than that of the Wistar controls.  
 
(n) refers to number of curves 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Vmax (nl 𝑶𝟐/(𝒄𝒎
𝟑*s))  P50 (mmHg) a 
Wistar 
(23) 131.9 ± 8.7  8.0 ± 0.6 2.1 ± 0.1 
G-K 
(14) 215.9 ± 23.0  8.5 ± 0.5 2.1 ± 0.1 
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Blood Glucose 
 
 
 The blood glucose level of each rat was measured using an AlphaTrak Blood 
Glucose Monitoring System (Zoetis Inc., Kalamazoo, MI) before and after each 
experiment. The readings can be considered non-fasting because the rats had 
continuous access to food in their cages and their eating habits were not carefully 
monitored. The blood glucose level for the Wistar control group was 223.3 ± 29.9 (SE) 
mg/dL. The Goto-Kakizaki rats had a blood glucose level of 580.5 ± 42.0 (SE) mg/dL. 
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Rat Sub-strain Wistar Goto-Kakizaki 
Glucose Level (mg/dL) 223.3 ± 29.9  580.5 ± 42.0 
 
 
 
 
Table 2. Mean non-fasting glucose levels in Wistar and Goto-Kakizaki rats. 
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Discussion 
 
 
Major Findings 
 
 The major finding in this project was that the maximal rate of oxygen 
consumption in rat spinotrapezius muscle measured using phosphorescence 
quenching microscopy was significantly higher in Goto-Kakizaki rats compared to 
Wistar controls: Goto-Kakizaki, Vmax = 215.9 ± 23.0 nl 𝑂2/(𝑐𝑚
3*s) and Wistar, Vmax = 
131.9 ± 8.7 nl 𝑂2/(𝑐𝑚
3*s)). This finding indicates that, in an animal model for type 2 
diabetes mellitus, a resting striated muscle has an elevated rate of oxygen 
consumption in the upper range of PO2. The PO2 at half maximal rate of consumption 
was not significantly different in Goto-Kakizaki and Wistar rats (Goto-Kakizaki, P50 = 
8.5 ± 1.9 mmHg and Wistar, P50 = 8.0 ± 3.0 mmHg). Additionally, based on these 
results for P50, it is important to note that the PO2 dependence of oxygen consumption 
in rat spinotrapezius muscle does cover a wide range of physiological PO2 values in 
both Wistar and the diseased animal model. Previous studies on the sensing of oxygen 
by isolated cells and mitochondria (Wilson, 1985) have shown that mitochondria 
consume oxygen at a constant rate regardless of oxygen tension until PO2 falls below 
about 1 mmHg. The P50 values calculated in this study and previous studies on the 
spinotrapezius muscle of male Sprague-Dawley rats (Golub, A. S., & Pittman, R. N., 
2003) suggest that the range of sensitivity to PO2 is much wider. Furthermore, the 
range is consistently wide in the spinotrapezius muscles of spontaneously T2DM rats 
and Wistar controls. 
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Oxygen Disappearance Curves 
 
 The oxygen disappearance curves (examples in Figures 2 and 3) collected from 
both the Wistar and G-K rats clearly display the previously observed behavior of the 
spinotrapezius muscle from Sprague-Dawley rats in terms of oxygen consumption 
over time. The 10 seconds of data collected before airbag inflation/tissue 
compression show the baseline PO2. This PO2 value represents the amount of oxygen 
that is maintained in equilibrium in the interstitial fluid by the inflow of oxygenated 
blood through the microcirculation and consumption by the tissue. On average, the G-
K rats had a higher baseline PO2 compared to the Wistar controls. At 10 seconds, 
when the airbag was inflated and blood flow was arrested, that equilibrium was 
disturbed. There was no longer oxygen bound to hemoglobin flowing into the area, so 
the PO2 immediately began to decrease in proportion to the rate of oxygen 
consumption by the muscle. The initial slope of the line is near linear, indicating that 
the rate of consumption is not very dependent on PO2 at those levels. As the oxygen 
tension continues to drop, due to continued consumption without replenishment of 
oxygen from the blood, the line begins to curve downward exponentially until it 
reaches approximately zero mmHg. The point at which the line stops behaving 
linearly marks a critical point at which the tissue consumption rate starts to decrease 
with decreasing PO2 levels. The difference in the time at initial compression to the 
time the curve reaches approximately 0 mmHg represents the total amount of time 
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required for the tissue to consume all the available oxygen in the interstitial space. 
This ranged from 30-45 seconds in both Wistar and G-K rats. 
 
 
VO2 vs. PO2 Plots 
 
 Figures 4 and 5 display the plots of the PO2 dependence of oxygen 
consumption for a Wistar and - rat, respectively. The data were fit with Hill’s equation 
to provide a non-linear fit line and several key parameters. Vmax is used to describe the 
maximum rate of consumption by the given muscle in the tissue region being 
measured. Another useful parameter for describing this relationship is P50, which is 
equal to the PO2 at half - maximal consumption rate. A higher P50 indicates that the 
oxygen consumption rate is dependent on a wider range of PO2 values. On average, 
the G-K rats had a higher, but non-significant, P50, compared to the Wistar rats. 
 
Explanation for Increased Vmax in G-K rats 
 
If the skeletal muscle of diabetic rats consumes oxygen at a higher average 
maximal rate, one explanation could be that there is an “uncoupling” of O2 
consumption and ATP production in the mitochondria that leads to less efficient 
production of ATP and a higher requirement for oxygen. In that case, a given cell 
would need to consume more oxygen in order to produce the same amount of ATP 
required for normal cellular processes. This may lead to a higher maximal rate of 
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oxygen consumption in skeletal muscle at resting conditions. The term “mitochondrial 
uncoupling” can be used to describe any situation in which the electron transport 
chain is not used to produce ATP or create proton gradients (Mookerjee SA, 2010). If a 
situation were to arise in which oxygen was still being consumed through oxidative 
phosphorylation, but the proton gradient was not being created as efficiently and ATP 
was not being produced at the same rate, the cell may have to compensate by 
increasing the rate of respiration. This would make up for the decreased energy 
production and also consume oxygen at a higher rate, leading to a higher Vmax. 
 
In related studies, it has been shown that the mitochondria in diabetic rats are 
smaller and fewer in number (Morino K, 2005). This would logically suggest that 
overall consumption of oxygen by mitochondria in a particular cell or tissue would be 
lower than that of a healthy control. In fact, it has been demonstrated that muscle 
oxidative phosphorylation in diabetic rats was impaired (Kelley DE, 2002, Sivitz, 
William I, 2016). This appears contradictory to the results of this study, because 
decreased oxidative phosphorylation should result in less oxygen being consumed by 
the cell and less ATP being produced. 
 
 As described before, the classic view of ATP production involves oxidative 
phosphorylation and anaerobic glycolysis as separate processes that are carried out 
independently based on oxygen availability. In physiologically oxygen-rich 
environments, the cell will choose to produce energy more efficiently through 
oxidative phosphorylation and conversely, using glycolysis with the production of 
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lactate in environments where oxygen is unavailable. This either/or scenario fits well 
with the classic view that mitochondria consume oxygen at a steady rate throughout 
most of the physiological range until PO2 drops below about 1 mmHg. This would 
suggest that oxidative phosphorylation is the sole process producing ATP until PO2 
levels fall to nearly zero.  
The in vivo PQM technique used in this project demonstrates that the 
mitochondria appear to consume oxygen at rates that are dependent on PO2 over a 
much wider physiological range. Since the rate of consumption varies based on 
oxygen tension, it may be the case that oxidative phosphorylation and glycolysis work 
simultaneously at a ratio that is dependent on PO2. In situations where PO2 is 
decreasing, for example, the cell would increasingly shift to using glycolysis to 
produce some of its ATP. Furthermore, when oxygen is abundant, the cell would shift 
to a higher utilization of oxidative phosphorylation. This PO2-dependent ratio of 
oxidative phosphorylation and glycolysis differs from the classic view, but is more 
consistent with the oxygen dependence of respiration described in this project and 
previous similar studies (Golub, 2012). 
The differences in values for half maximal respiration reported in earlier 
studies (Chance B., 1988) and those reported by Golub and Pittman are likely due to 
technical limitations. In the older studies, in-vitro techniques were used that involved 
suspensions of mitochondria or cells to measure oxygen consumption. A variety of 
error sources were likely introduced that led to vastly different results. Those 
potential sources of error were dramatically reduced when the in-vivo technique was 
implemented. 
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Figure 6. This is an illustration of the possible relationship between oxidative 
phosphorylation and glycolysis based on variations in PO2. In this diagram, if PO2 falls, 
the utilization of oxidative phosphorylation proportionally decreases as glycolysis 
increases. 
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Limitations and Future Studies 
 
Although blood glucose concentrations were measured before and after each 
experiment, these animals were not fasted and it was not possible to determine how 
recently they had consumed rat chow. A more controlled eating schedule prior to 
experimentation may provide more consistent blood glucose levels. To monitor blood 
glucose, a single glucose reading was taken with the hand held glucometer. A more 
continuous system to monitor glucose may provide interesting correlations in oxygen 
consumption and glucose levels. 
The rate of blood flow in the muscle was not measured in this project. Since 
blood flow is directly related to oxygen delivery to muscles, measuring this variable 
could improve the understanding of oxygen consumption measurements. 
Additionally, the muscles studied were at rest. Inducing contraction while 
measuring PO2 could help show how consumption rates are affected by an actively 
contracting muscle in healthy and diabetic rats. 
It is relevant to note that a relatively small number of muscles were studied. 
More trials would be beneficial to more strongly validate the results obtained in this 
project and help clarify the observed differences in G-K and Wistar oxygen 
consumption characteristics. 
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The PQM technique used in this study utilized a 1 Hz flash rate, which provided 
a PO2 reading every second. In future studies, the frequency of the laser flash rate 
could be increased to provide improved PO2 resolution of the curves describing the 
PO2 dependence of VO2. This would, of course, require a different correction for the 
magnitude of photo-consumption by the method. More accurate Hill parameters may 
come from an increased flash frequency. Additionally, one could study oxygen 
consumption rate in diseased rats of different ages. The symptoms of the G-K rats 
used in this study progress over time much like the disease progresses in human 
diabetic patients. It would be interesting to compare an older, more “end-stage” 
diabetic rat with higher rates of microvascular complications to a younger rat. Since 
this method for studying the PO2 dependence of oxygen consumption is relatively 
new, it would also be beneficial to determine if other chronic diseases such as 
hypertension or obesity would have an effect on consumption rates. 
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Conclusion 
 
 In conclusion, this project utilized a method of measuring the PO2 of the 
interstitial fluid in spinotrapezius muscles of diabetic and non-diabetic rats. By 
arresting blood flow, the rate of oxygen disappearance due to respiration was 
calculated and differences between diseased and control rats were studied. The 
maximum rate of consumption for G-K rats was significantly higher than that of the 
Wistar control rats. The P50 for both rat sub-strains demonstrated oxygen 
consumption rates that depended on PO2 over a wide physiological range. This 
elevated maximum rate of consumption in spontaneously diabetic rats should be 
investigated further to help better understand the effect of the disease on cellular 
respiration and on functional consequences of a mismatch between oxygen supply 
and demand. 
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Appendix 
 
 
Wistar VO2 vs. PO2 plots 
 
A – PO2 (mmHg) 
 
B- VO2 (nl O2/(cm
3*s)) 
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Adj. R-Square 0.98966
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 Hill Fit of B
B
A
Model Hill
Equa tion y=Vmax*x n^ /( k^ n+x n^)
Plot B
Vmax 188.62 433 ± 6.18597
k 9.71 077 ± 0.4347
n 2.43 331 ± 0.16749
Reduced Chi-Sqr 29.118 75
R-Squa re(COD) 0.9884 7
Adj. R-Squa re 0.98 8
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 Hill Fit of B
B
A
Model Hill
Equation y=Vm ax* x^ n/(k n^+ x^ n)
Plo t B
Vm ax 181.406 ± 3.079 41
k 6.54282 ± 0.200 04
n 2.27425 ± 0.089 04
Reduced Chi-Sqr 14 .06803
R-Square(COD) 0 .9 9449
Adj. R-Sq uare 0 .9 9428
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 Hill Fit of B
B
A
Model Hill
Equation y=Vm ax* x^ n/(k n^ +x^ n)
Plot B
Vm ax 1 59.90353 ± 2.01 326
k 5.80552 ± 0.16 947
n 2.35657 ± 0.09 951
Reduced Chi-Sqr 1 6.36424
R-Square(COD) 0.99469
Adj. R-Square 0.99449
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 Hill Fit of B
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A
Model Hill
Equ atio n y=Vmax*x n^ /(k n^+x n^)
Plot B
Vmax 160 .1 178 ± 2.65259
k 5.62 562 ± 0.19174
n 2.38 997 ± 0.11494
Reduced Chi-Sq r 19.31 022
R-Squ are(COD) 0.992 46
Adj. R-Squa re 0.992 18
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 Hill Fit of B
B
A
Mode l Hil
Equation y=Vm ax* x^ n/(k^n+x^ n)
Plot B
Vm ax 149.36264  ±  2.07327
k 5.44872 ±  0 .2 2363
n 2.18105 ±  0 .1 1943
Redu ced  Chi- Sqr 29.15326
R-Square( COD) 0.99207
Ad j. R-Square 0.99178
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 Hill Fit of B
B
A
Model Hill
Equa tio n y=Vmax*x n^ /( k n^+x n^)
Plot B
Vmax 147.4 4508 ± 2.06697
k 5.57 666 ± 0.20948
n 2.18 851 ± 0.11042
Reduced Chi-Sqr 23.16 84
R-Squa re(COD) 0.99 29
Adj. R-Squa re 0.992 64
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 Hill Fit of B
B
A
Model Hill
Equa tion y=Vmax*x n^ /( k^ n+x n^)
Plot B
Vmax 162.19 218 ± 2.98407
k 6.35 879 ± 0.33763
n 1.97 473 ± 0.12386
Reduced Chi-Sqr 48.482 3
R-Squa re(COD) 0.9882 7
Adj. R- Squa re 0.9878 6
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 Hill Fit of B
B
A
Model Hill
Equ atio n y=Vmax*x^n/(k n^+x n^)
Plot B
Vmax 85.0 1921 ± 3.86589
k 9.1 7189 ± 0.82639
n 2.4 4734 ± 0.35395
Reduced Chi-Sq r 105.17 426
R-Squ are(COD) 0.923 46
Adj. R-Squa re 0.919 82
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 Hill Fit of B
B
A
Mo del Hill
Equa tion y=Vmax*x n^/( k^ n+x n^)
Plot B
Vmax 77.009 22 ± 2.40531
k 5.229 11 ± 0.48852
n 1.615 83 ± 0.16871
Re duced Chi-Sqr 40.909 8
R- Squa re(COD) 0.9640 8
Adj. R- Squar e 0.9627 3
/ODC	ANALYSIS	04062017/032517/	
21	
0 10 20 30 40 50
0
20
40
60
80
100
 B
 Hill Fit of B
B
A
Model Hill
Equa tion y=Vmax*x n^ /( k^ n+x n^)
Plot B
Vmax 72 .4 8772 ± 1.661
k 4.48 232 ± 0.29126
n 1.98 879 ± 0.1879
Reduced Chi-Sqr 25.512 07
R-Squa re(COD) 0.9761 8
Adj. R-Squa re 0.9752 3
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 Hill Fit of B
B
A
Model Hill
Equ ation y=Vma x* x^ n/(k n^+x n^ )
Plot B
Vma x 75 .0 1744 ± 1.7209 9
k 4 .5 1352 ± 0.2991 6
n 1 .9 6029 ± 0.1817 9
Reduced Chi-Sq r 26 .9 509
R-Squ are(COD) 0.97 646
Adj. R-Squ are 0.97 555
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Goto-Kakizaki VO2 vs. PO2 plots 
 
A – PO2 (mmHg) 
 
B- VO2 (nl O2/(cm
3*s)) 
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 Hill Fit of B
B
A
Mo del Hill
Equation y= Vmax*x n^/( k^ n+x n^)
Plot B
Vmax 279.949 75 ± 6.11128
k 8.298 1 ± 0.47513
n 1.888 4 ± 0.12679
Re duced Chi-Sqr 107.902 6
R- Squar e(COD) 0.98824
Adj. R- Squar e 0.9878
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 Hill Fit of B
B
A
Model Hill
Equation y=Vm ax* x^ n/(k n^+ x^ n)
Plo t B
Vm ax 3 89.68693 ± 4.98 116
k 8.55397 ± 0.288 76
n 1.59436 ± 0.054 33
Reduced Chi-Sqr 3 5.9158
R-Square(COD) 0 .9 9722
Adj. R-Square 0 .9 9712
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 Hill Fit of B
B
A
Model Hill
Equation y=Vm ax* x^ n/(k n^+ x^ n)
Plo t B
Vm ax 2 79.94975 ± 6.11 128
k 8.2981 ± 0.475 13
n 1.8884 ± 0.126 79
Reduced Chi-Sqr 1 07.9026
R-Square(COD) 0 .98824
Adj. R-Square 0.9878
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 Hill Fit of B
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Model Hill
Equation y=Vm ax* x^ n/(k n^ +x^ n)
Plot B
Vm ax 297.47948 ± 9.4 2824
k 10.6238 ± 0.89 323
n 1.94444 ± 0.17 757
Reduced Chi-Sqr 3 17.18324
R-Square( COD) 0.97253
Adj. R-Square 0.97154
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 Hill Fit of B
B
A
Model Hill
Equation y=Vm ax* x^ n/(k n^+ x^ n)
Plo t B
Vm ax 2 67.18587 ± 5.43 979
k 9.5974 ± 0.498 5
n 3.01322 ± 0.2 8
Reduced Chi-Sqr 23 8.08461
R-Square(COD) 0 .9 7848
Adj. R-Sq uare 0 .9 7772
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 Hill Fit of B
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Model Hill
Equ atio n y=Vmax*x n^ /(k n^+x n^)
Plot B
Vmax 122 .9 6792 ± 3.8564 5
k 7.53 877 ± 0.59113
n 1.86 655 ± 0.15973
Reduced Chi-Sq r 66.29 885
R-Squa re(COD) 0.973 45
Adj. R-Squa re 0.972 51
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 Hill Fit of B
B
A
Model Hill
Equa tion y=Vmax*x n^/( k^ n+x n^)
Plot B
Vmax 120.69 245 ± 3.11904
k 6.432 38 ± 0.43651
n 2.068 23 ± 0.16856
Reduced Chi-Sqr 57.155 84
R-Squa re(COD) 0.9767 9
Adj. R- Squar e 0.9759 8
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 Hill Fit of B
B
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Mod el Hill
Equation y=Vmax*x n^/(k^n+x^ n)
Plot B
Vmax 112.497 1 ± 3.07093
k 5.9220 9 ± 0.4697
n 2.0804 9 ± 0.19995
Red uce d Ch i- Sqr 74.75401
R-Squar e(COD) 0.96895
Adj. R-Square 0.96786
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 Hill Fit of B
B
A
Model Hill
Eq uation y=Vma x* x^ n/(k n^+x n^ )
Plot B
Vma x 9 7.7647 ± 2.1820 5
k 5 .8 4953 ± 0.3389 2
n 2 .1 5551 ± 0.1650 1
Reduced Chi-Sqr 34.3 9247
R-Sq uare(COD) 0.98 075
Adj. R-Squ are 0.98 002
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 Hill Fit of B
B
A
Mo del Hill
Equation y=Vmax*x n^ /( k^ n+x n^)
Plot B
Vmax 171.91 689 ± 10.78466
k 11.91 036 ± 1.61072
n 1.33 244 ± 0.10791
Re duced Chi-Sqr 67.544 68
R- Squar e(COD) 0.9765 1
Adj. R- Squar e 0.9756 6
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 Hill Fit of B
B
A
Model Hill
Eq uation y=Vma x* x^ n/(k n^+x^n)
Plot B
Vm ax 24 8.97382 ± 8.935 48
k 1 0.75991 ± 0.5195 5
n 2 .65211 ± 0.1630 3
Reduced Chi-Sqr 62 .4 9036
R-Sq uare(COD) 0.98 092
Adj. R-Sq uare 0.98 024
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 Hill Fit of B
B
A
Model Hill
Equation y=Vm ax* x^ n/(k n^ +x^ n)
Plot B
Vm ax 245.46816 ± 6.8 4574
k 7.47523 ± 0.39 648
n 2.08 ± 0.115 35
Reduced Chi-Sqr 4 9.56941
R-Square( COD) 0.98715
Adj. R-Square 0.98669
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 Hill Fit of B
B
A
Model Hil
Equation y=Vm ax* x^ n/(k^n+x^ n)
Plot B
Vm ax 158.01662  ±  3 .68596
k 8.50167 ±  0 .4 6393
n 1.70049 ±  0 .0 9142
Reduced  Chi-Sqr 32.21831
R-Square( COD) 0.9909
Ad j. R-Square 0.99054
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 Hill Fit of B
B
A
Model Hill
Equation y=Vm ax* x^ n/(k n^ +x^ n)
Plot B
Vm ax 243.53724 ± 5 .0 5685
k 7.5811 ± 0.30 256
n 1.99334 ± 0.08 641
Reduced Chi-Sqr 26.64656
R-Square( COD) 0.99397
Adj. R-Square 0.99373
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